Multiple shRNAs driven by U6 and CMV promoter enhances efficiency of antiviral effects against foot-and-mouth disease virus

Antiviral Research

Volumn 87, Issue 3, 2010, Pages 307-317

  Kim, Su Mi ^a,b   Lee, Kwang Nyeong ^a   Lee, Su Jung ^a   Ko, Young Joon ^a   Lee, Hyang Sim ^a   Kweon, Chang Hee ^a   Kim, Hyun Soo ^b   Park, Jong Hyeon ^a  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Adenovirus; Foot and mouth disease virus; Multiple shRNAs; Promoters; Small interference RNA

Indexed keywords

AD U62B U63C1; ADENOVIRUS VECTOR; ALPHA INTERFERON; BETA INTERFERON; DNA DIRECTED RNA POLYMERASE III; INTERFERON; RNA POLYMERASE II; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE EXPRESSION; GENE SILENCING; INOCULATION; LD 50; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; SEROTYPE; SURVIVAL RATE; VIRUS INHIBITION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; MUS;

EID: 77955843314     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.06.004     Document Type: Article

References (38)

1. Abbas A.K., Lichtman A.H. Cellular and Molecular Immunology 2003, Elsevier Science Publisher, pp. 260-261. 5th edition.
2. An D.S., Qin F.X., Auyeung V.C., Mao S.H., Kung S.K., Baltimore D., Chen I.S. Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. Mol. Ther. 2006, 14:494-504.
3. Bachrach H.L. Foot-and-mouth disease. Annu. Rev. Microbiol. 1968, 22:201-244.
4. Carrillo C., Tulman E.R., Delhon G., Lu Z., Carreno A., Vagnozzi A., Kutish G.F., Rock D.L. Comparative genomics of foot-and-mouth disease virus. J. Virol. 2005, 79:6487-6504.
5. Chen W., Liu M., Jiao Y., Yan W., Wei X., Chen J., Fei L., Liu Y., Zuo X., Yang F., Lu Y., Zheng Z. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo. J. Virol. 2006, 80:3559-3566.
6. Chen W., Yan W., Du Q., Fei L., Liu M., Ni Z., Sheng Z., Zheng Z. RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice. J. Virol. 2004, 78:6900-6907.
7. Chen Y., Mahato R.I. siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection. J. Drug Target 2008, 16:140-148.
8. Chinsangaram J., Koster M., Grubman M.J. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 2001, 75:5498-5503.
9. Darcan-Nicolaisen Y., Meinicke H., Fels G., Hegend O., Haberland A., Kuhl A., Loddenkemper C., Witzenrath M., Kube S., Henke W., Hamelmann E. Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice. J. Immunol. 2009, 182:7501-7508.
10. de los Santos T., de Avila Botton S., Weiblen R., Grubman M.J. The leader protease of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 2005, 80:1906-1914.
11. Gitlin L., Stone J.K., Andino R. Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J. Virol. 2005, 79:1027-1035.
12. Gonzalez S., Castanotto D., Li H., Olivares S., Jensen M.C., Forman S.J., Rossi J.J., Cooper L.J. Amplification of RNAi - targeting HLA mRNAs. Mol. Ther. 2005, 11:811-818.
13. Grimm D., Kay M.A. Combinatorial RNAi: a winning strategy for the race against evolving targets?. Mol. Ther. 2007, 15:878-888.
14. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., Kay M.A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006, 441:537-541.
15. Hall T.A. Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 1999, 41:95-98.
16. Hamasaki K., Nakao K., Matsumoto K., Ichikawa T., Ishikawa H., Eguchi K. Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett. 2003, 543:51-54.
17. Jacque J.M., Triques K., Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002, 418:435-438.
18. Kahana R., Kuznetzova L., Rogel A., Shemesh M., Hai D., Yadin H., Stram Y. Inhibition of foot-and-mouth disease virus replication by small interfering RNA. J. Gen. Virol. 2004, 85:3213-3217.
19. Kim S.M., Lee K.N., Park J.Y., Ko Y.J., Joo Y.S., Kim H.S., Park J.H. Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo. Antiviral Res. 2008, 80:178-184.
20. Knowles N.J., Samuel A.R. Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 2003, 91:65-80.
21. Lee N.S., Rossi J.J. Control of HIV-1 replication by RNA interference. Virus Res. 2004, 102:53-58.
22. Lo H.L., Chang T., Yam P., Marcovecchio P.M., Li S., Zaia J.A., Yee J.K. Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters. Gene Ther. 2007, 14:1503-1512.
23. Mäkinen P.I., Koponen J.K., Kärkkäinen A.M., Malm T.M., Pulkkinen K.H., Koistinaho J., Turunen M.P., Ylä-Herttuala S. Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain. J. Gene Med. 2006, 8:433-441.
24. O'Brien L. Inhibition of multiple strains of Venezuelan equine encephalitis virus by a pool of four short interfering RNAs. Antiviral Res. 2007, 75:20-29.
25. Pereira H.G. Foot-and-Mouth Disease Animals 1981, Academic Press, New York, NY, pp. 333-363.
26. Persengiev S.P., Zhu X., Green M.R. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 2004, 10:12-18.
27. Pusch O., Boden D., Silbermann R., Lee F., Tucker L., Ramratnam B. Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA. Nucleic Acids Res. 2003, 31:6444-6449.
28. Reed L.I., Muench H. A simple method of estimating fifty percent end points. Am. J. Hygiene 1938, 27:493-497.
29. Ren G.L., Fang Y., Ma H.H., Lei Y.F., Wang D., Xu M.C., Wang P.Z., Huang C.X., Nie O.H., Sun Y.T., Bai X.F. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains. Antivir. Ther. 2007, 12:865-876.
30. Ryman K.D., Klimstra W.B., Nguyen K.B., Biron C.A., Johnston R.E. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J. Virol. 2000, 74:3366-3378.
31. Sabariegos R., Giménez-Barcons M., Tàpia N., Clotet B., Martínez M.A. Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs. J. Virol. 2006, 80:571-577.
32. Saulnier A., Pelletier I., Labadie K., Colbère-Garapin F. Complete cure of persistent virus infections by antiviral siRNAs. Mol. Ther. 2006, 13:142-150.
33. Song J., Giang A., Lu Y., Pang S., Chiu R. Multiple shRNA expressing vector enhances efficiency of gene silencing. BMB Rep. 2008, 41:358-362.
34. ter Brake O., Konstantinova P., Ceylan M., Berkhout B. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol. Ther. 2006, 14:883-892.
35. ter Brake O., t Hooft K., Liu Y.P., Centlivre M., von Eije K.J., Berkhout B. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol. Ther. 2008, 16:557-564.
36. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
37. Wu K., Mu Y., Hu J., Lu L., Zhang X., Yang Y., Li Y., Liu F., Song D., Zhu Y., Wu J. Simultaneously inhibition of HIV and HBV replication through a dual small interfering RNA expression system. Antiviral Res. 2007, 74:142-149.
38. Wu K.L., Zhang X., Zhang J., Yang Y., Mu Y.X., Liu M., Lu L., Li Y., Zhu Y., Wu J. Inhibition of Hepatitis B virus gene expression by single and dual small interfering RNA treatment. Virus Res. 2005, 112:100-107.